Groupama Asset Managment Has $1.31 Million Stock Position in McKesson Co. (NYSE:MCK)

Groupama Asset Managment cut its stake in shares of McKesson Co. (NYSE:MCK) by 4.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,295 shares of the company’s stock after selling 109 shares during the period. Groupama Asset Managment’s holdings in McKesson were worth $1,310,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of MCK. Millstone Evans Group LLC bought a new position in shares of McKesson in the fourth quarter valued at $28,000. Synergy Asset Management LLC bought a new position in shares of McKesson in the 4th quarter valued at about $32,000. Crews Bank & Trust acquired a new position in shares of McKesson during the 4th quarter worth about $33,000. Atala Financial Inc bought a new stake in shares of McKesson in the 4th quarter valued at about $34,000. Finally, Graney & King LLC acquired a new stake in McKesson in the 4th quarter valued at about $38,000. 85.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on MCK. Citigroup dropped their price objective on McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Bank of America dropped their price target on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com cut shares of McKesson from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Wells Fargo & Company increased their price objective on shares of McKesson from $641.00 to $691.00 and gave the company an “equal weight” rating in a research report on Friday, March 14th. Finally, Morgan Stanley lifted their target price on shares of McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a report on Wednesday. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $656.71.

Insider Buying and Selling

In related news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the transaction, the chief executive officer now owns 60,664 shares of the company’s stock, valued at $36,276,465.36. This represents a 12.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Leann B. Smith sold 188 shares of the business’s stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,110 shares of company stock worth $10,855,706 in the last ninety days. 0.11% of the stock is owned by insiders.

McKesson Stock Up 3.0 %

MCK stock opened at $694.12 on Thursday. The company has a market cap of $86.99 billion, a PE ratio of 31.78, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $695.46. The business has a 50-day simple moving average of $629.16 and a 200 day simple moving average of $582.85.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd were issued a dividend of $0.71 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.41%. McKesson’s dividend payout ratio (DPR) is currently 13.00%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.